Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-M Freyssinet

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Cellular and Molecular Life Sciences : CMLS|December 8, 2004
Modulation of signal transduction through the cellular prion protein is linked to its incorporation in lipid raftsB Hugel, M C Martínez, C Kunzelmann, et al.
The Biochemical Journal|December 1, 1988
Interference of blood-coagulation vitamin K-dependent proteins in the activation of human protein C. Involvement of the 4-carboxyglutamic acid domain in two distinct interactions with the thrombin-thrombomodulin complex and with phospholipidsJ M Freyssinet, A Beretz, C Klein-Soyer, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|April 9, 2005
[Microparticles and cardiovascular disease]O Morel, P Ohlmann, N Morel, et al.
Biochemical Society Transactions|January 1, 1977
Factor XIII: a study using polarization of fluorescence of the activation of the enzyme by calcium and by substrate [proceedings]J J Holbrook, B A Lewis, J M Freyssinet, et al.
The Biochemical Journal|February 1, 1991
Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol esterG Archipoff, A Beretz, J M Freyssinet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 13, 2005
[Procoagulant membranous microparticles and atherothrombotic complications in diabetics]O Morel, B Hugel, L Jesel, et al.
Blood|May 15, 1993
Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groupsJ Dachary-Prigent, J M Freyssinet, J M Pasquet, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
Physiopathological significance of catalytic phospholipids in the generation of thrombinJ Dachary-Prigent, F Toti, N Satta, et al.
British Journal of Haematology|May 12, 1998
Impaired redistribution of aminophospholipids with distinctive cell shape change during Ca2+-induced activation of platelets from a patient with Scott syndromeN Bettache, P Gaffet, N Allegre, et al.
Blood|May 11, 1999
Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemiaB Hugel, G Socié, T Vu, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Cellular and Molecular Life Sciences : CMLS|December 8, 2004
Modulation of signal transduction through the cellular prion protein is linked to its incorporation in lipid raftsB Hugel, M C Martínez, C Kunzelmann, et al.
The Biochemical Journal|December 1, 1988
Interference of blood-coagulation vitamin K-dependent proteins in the activation of human protein C. Involvement of the 4-carboxyglutamic acid domain in two distinct interactions with the thrombin-thrombomodulin complex and with phospholipidsJ M Freyssinet, A Beretz, C Klein-Soyer, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|April 9, 2005
[Microparticles and cardiovascular disease]O Morel, P Ohlmann, N Morel, et al.
Biochemical Society Transactions|January 1, 1977
Factor XIII: a study using polarization of fluorescence of the activation of the enzyme by calcium and by substrate [proceedings]J J Holbrook, B A Lewis, J M Freyssinet, et al.
The Biochemical Journal|February 1, 1991
Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol esterG Archipoff, A Beretz, J M Freyssinet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 13, 2005
[Procoagulant membranous microparticles and atherothrombotic complications in diabetics]O Morel, B Hugel, L Jesel, et al.
Blood|May 15, 1993
Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groupsJ Dachary-Prigent, J M Freyssinet, J M Pasquet, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
Physiopathological significance of catalytic phospholipids in the generation of thrombinJ Dachary-Prigent, F Toti, N Satta, et al.
British Journal of Haematology|May 12, 1998
Impaired redistribution of aminophospholipids with distinctive cell shape change during Ca2+-induced activation of platelets from a patient with Scott syndromeN Bettache, P Gaffet, N Allegre, et al.
Blood|May 11, 1999
Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemiaB Hugel, G Socié, T Vu, et al.
Pageof 10